Tecentriq SQ FDA approval

Atezolizumab and hyaluronidase-tqjs is approved by FDA for subcutaneous injection

On September 12, 2024, the Food and Drug Administration sanctioned atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) for subcutaneous administration for all adult indications co...
tecentriq-sq-fda-approval

Scan the code

Tag: Tecentriq SQ FDA approval

Home / Tecentriq SQ FDA approval

Categories

Atezolizumab and hyaluronidase-tqjs is approved by FDA for subcutaneous injection

Information

Treatment

United States

Romania

India (Hyderabad)

Cambodia

China (Shanghai)

China (Beijing)

Hong Kong